Saturday, 7 September 2013

AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3 trial » All About Drugs

AstraZeneca began a pivotal trial with selumetinib , thyroid cancer, Phase 3 trial » All About Drugs:

'via Blog this'

No comments:

Post a Comment